Page 54 - Current Reports News Today

Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, today announced that the U.S. Food and Drug Administration has accepted for priority review...

TheScore Founding Leaders to Step Down from PENN Interactive Following the Successful Rollout of ESPN BET and theScore Bet, and In-House Technology Migration ...

/PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the fourth quarter and full-year ended December...

PRINCETON, N.J.--(BUSINESS WIRE)--Jan 30, 2024--

MINNEAPOLIS, Jan. 30, 2024 -- Panbela Therapeutics, Inc. , a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced...

WARREN, N.J., Jan. 30, 2024 -- Aquestive Therapeutics, Inc. , a pharmaceutical company advancing medicines to bring meaningful improvement to patients lives through innovative science and delivery...

Permian Resources Corporation today announced a series of recent portfolio optimization transactions consisting of two bolt-on acquisitions, a sizeable acreage swap, a divestiture of non-core...

The Phase II clinical trial in patients with Alzheimer’s disease with neuroinflammation is on track to complete enrollment mid-2024 with top line data expected approximately six months after the...

The Phase II clinical trial in patients with Alzheimer’s disease with neuroinflammation is on track to complete enrollment mid-2024 with top line data expected approximately six months after the final

U.S. FDA grants both FL and MCL applications Priority Review Applications based on results from TRANSCEND FL and TRANSCEND NHL 001, in which Breyanzi demonstrated clinically meaningful benefit with...